Literature DB >> 5113466

Eck's fistula encephalopathy in germfree dogs.

F C Nance, D G Kline.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5113466      PMCID： PMC1397554          DOI： 10.1097/00000658-197111000-00018

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  23 in total

1.  Gastric urease activity in normal subjects and in subjects with cirrhosis.

Authors:  W J RAPPOPORT; F KERN
Journal:  J Lab Clin Med       Date:  1963-04

2.  The location and origin of gastric urease.

Authors:  E J CONWAY; O FITZGERALD; K McGEENEY; F GEOGHEGAN
Journal:  Gastroenterology       Date:  1959-10       Impact factor: 22.682

3.  The bacterial content of the small intestine in normal and cirrhotic subjects: relation to methionine toxicity.

Authors:  G A MARTINI; E A PHEAR; B RUEBNER; S SHERLOCK
Journal:  Clin Sci       Date:  1957-02       Impact factor: 6.124

4.  The in vitro production of ammonium and amines by intestinal bacteria in relation to nitrogen toxicity as a factor in hepatic coma.

Authors:  E A PHEAR; B RUEBNER
Journal:  Br J Exp Pathol       Date:  1956-06

5.  Episodic stupor associated with an Eck fistula in the human with particular reference to the metabolism of ammonia.

Authors:  W V McDERMOTT; R D ADAMS
Journal:  J Clin Invest       Date:  1954-01       Impact factor: 14.808

6.  The Effect of Antibiotics on Urea Breakdown in Mice.

Authors:  R Z Dintzis; A B Hastings
Journal:  Proc Natl Acad Sci U S A       Date:  1953-07       Impact factor: 11.205

7.  Effect of ammonium chloride and urea infusions on ammonium levels and acidity of gastric juice.

Authors:  B Fleshler; G J Gabuzda
Journal:  Gut       Date:  1965-08       Impact factor: 23.059

8.  Ammonia metabolism in the gut.

Authors:  W H Summerskill; E Wolpert
Journal:  Am J Clin Nutr       Date:  1970-05       Impact factor: 7.045

9.  Treatment of chronic portal-systemic encephalopathy with lactulose.

Authors:  J Bircher; J Müller; P Guggenheim; U P Haemmerli
Journal:  Lancet       Date:  1966-04-23       Impact factor: 79.321

10.  Metabolic effects of oral neomycin.

Authors:  A M Asatoor; M J Chamberlain; B T Emmerson; J R Johnson; A J Levi; M D Milne
Journal:  Clin Sci       Date:  1967-08       Impact factor: 6.124
View more
  7 in total

Review 1.  Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives.

Authors:  Milan Holecek
Journal:  Metab Brain Dis       Date:  2013-08-31       Impact factor: 3.584

2.  Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis.

Authors:  Manuel Romero-Gomez; Maria Jover; Daniel Diaz-Gomez; Laura-Collantes de Teran; Regina Rodrigo; Ines Camacho; Miriam Echevarria; Vicente Felipo; Juan-D Bautista
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 3.  Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy.

Authors:  Manuel Romero-Gómez
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

4.  Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion.

Authors:  C W Putnam; K A Porter; T E Starzl
Journal:  Ann Surg       Date:  1976-08       Impact factor: 12.969

Review 5.  Gut ammonia production and its modulation.

Authors:  Manuel Romero-Gómez; María Jover; J Jorge Galán; A Ruiz
Journal:  Metab Brain Dis       Date:  2008-12-10       Impact factor: 3.584

6.  Astrocytes of the cerebral cortex in hepatosplenic schistosomiasis mansoni and in liver cirrhosis. A morphological, quantitative and karyometric study.

Authors:  J E Pittella
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

7.  THDP17 decreases ammonia production through glutaminase inhibition. A new drug for hepatic encephalopathy therapy.

Authors:  M Mar Díaz-Herrero; José A del Campo; Pilar Carbonero-Aguilar; José M Vega-Pérez; Fernando Iglesias-Guerra; Ignacio Periñán; Francisco J Miñano; Juan Bautista; Manuel Romero-Gómez
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.